Bloomios, Inc. engages in the manufacture, market, and distribution of U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels and its subsidiary. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. BPL is engaged in manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. BPL provides support at each step from custom formulation, order fulfilment, and brand development. The company offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 10 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, topicals, beverages and pet treats. The company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, and topicals.
Follow-Up Questions
¿Quién es el CEO de Bloomios Inc?
Mr. Michael Hill es el Chairman of the Board de Bloomios Inc, se unió a la empresa desde 2020.
¿Qué tal es el rendimiento del precio de la acción BLMS?
El precio actual de BLMS es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Bloomios Inc?
Bloomios Inc pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Bloomios Inc?
La capitalización bursátil actual de Bloomios Inc es $0
